Breaking News Instant updates and real-time market news.

RETA

Reata Pharmaceuticals

$213.50

1.46 (0.69%)

16:30
11/11/19
11/11
16:30
11/11/19
16:30

Reata Pharmaceuticals trading resumes

  • 12

    Nov

RETA Reata Pharmaceuticals
$213.50

1.46 (0.69%)

10/15/19
JEFF
10/15/19
NO CHANGE
Target $254
JEFF
Buy
Reata Pharmaceuticals price target raised to $254 from $128 at Jefferies
Jefferies analyst Maury Raycroft raised his price target for Reata Pharmaceuticals to $254 from $128 and and maintained a Buy rating, telling investors in a research note that the company's to-line data from the registrational Part 2 portion of the MOXIe Phase 2 trial of omaveloxolone in patients with Friedreich's ataxia seem "impressive" on the primary endpoint, and believes the unmet need and totality of data will be enough to get the drug approved. Raycroft says the positive FA results were "unexpected."
10/16/19
STFL
10/16/19
NO CHANGE
Target $210
STFL
Buy
Reata Pharmaceuticals price target raised to $210 from $135 at Stifel
Stifel analyst Adam Walsh increased his price target on Reata Pharmaceuticals to $210 from $135 after omaveloxolone in patients with Friedreich's ataxia hit the "FDA-blessed" primary endpoint of placebo-corrected mFARS in the MOXIe trial. He, and his key-opinion leader consultant, think omaveloxolone first-pass approval is likely based on the trial results reported, especially given the "benign" safety and tolerability, Walsh tells investors. Beyond omaveloxolone, he remains bullish ahead of Alport data due out this quarter, Walsh added.
10/16/19
LTCO
10/16/19
NO CHANGE
Target $239
LTCO
Buy
Reata Pharmaceuticals price target raised to $239 from $133 at Ladenburg
Ladenburg Thalmann analyst Matthew Kaplan raised his price target for Reata Pharmaceuticals to $239 from $133 after the company announced positive topline data from Part 2 of the MOXIe registrational trial of omaveloxolone in patients with Friedreich's ataxia. Importantly, omaveloxolone treatment not only halted the progression of the disease but actually showed improvement in the largest Friedreich's trial to date, Kaplan tells investors in a research note. He believes the data are sufficient as a registrational study for approval of omaveloxolone in Friedreich's Ataxia. The analyst reiterates a Buy rating on Reata Pharmaceuticals and says his new price target reflects to the increased probability of approval of omaveloxolone in Friedreich's ataxia.
11/04/19
CANT
11/04/19
NO CHANGE
Target $250
CANT
Overweight
Reata Pharmaceuticals price target raised to $250 from $180 at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan raised his price target for Reata Pharmaceuticals to $250 from $180 and keeps an Overweight rating on the shares. The analyst says results from his recent key opinion leader due diligence enhances his conviction in the clinical value for bardoxolone's Phase 3 Cardinal study in Alport syndrome.

TODAY'S FREE FLY STORIES

PYX

Pyxus

$7.58

-0.1 (-1.30%)

14:49
12/05/19
12/05
14:49
12/05/19
14:49
Hot Stocks
Pyxus' Figr Brands enters Ontario legal cannabis market »

Pyxus International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDR

Cloudera

$9.93

0.065 (0.66%)

14:49
12/05/19
12/05
14:49
12/05/19
14:49
Options
Cloudera options imply 20.8% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Dec

CC

Chemours

$15.04

-0.375 (-2.43%)

14:48
12/05/19
12/05
14:48
12/05/19
14:48
Periodicals
Chemours tells Bloomberg final agreement on PFAS designation not yet reached »

A Chemours spokesperson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

QCOM

Qualcomm

$82.18

0.1 (0.12%)

14:48
12/05/19
12/05
14:48
12/05/19
14:48
Hot Stocks
Qualcomm launches its XR2 platform for 'a new era of AR, VR and MR experiences' »

Qualcomm announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

TSM

TSMC

$54.38

1.21 (2.28%)

14:45
12/05/19
12/05
14:45
12/05/19
14:45
Options
Taiwan Semi call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$199.02

0.32 (0.16%)

14:39
12/05/19
12/05
14:39
12/05/19
14:39
Periodicals
Facebook sues Hong Kong's ILikeAd over claims of ad fraud, Reuters reports »

Facebook is suing a Hong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

NWE

NorthWestern

$71.86

0.11 (0.15%)

14:32
12/05/19
12/05
14:32
12/05/19
14:32
Hot Stocks
NorthWestern has new coal supply agreement for Colstrip »

NorthWestern Energy has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSREY

Swiss Re

$0.00

(0.00%)

, PNXGF

Phoenix Group

$0.00

(0.00%)

14:31
12/05/19
12/05
14:31
12/05/19
14:31
Periodicals
Breaking Periodicals news story on Swiss Re, Phoenix Group »

Phoenix Group in talks to…

SSREY

Swiss Re

$0.00

(0.00%)

PNXGF

Phoenix Group

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/05/19
12/05
14:17
12/05/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/05/19
12/05
14:16
12/05/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$90.26

0.095 (0.11%)

, ADI

Analog Devices

$113.87

-0.03 (-0.03%)

14:13
12/05/19
12/05
14:13
12/05/19
14:13
Hot Stocks
Xilinx says will 'vigorously defend' self against Analog Devices patent suit »

Xilinx, Inc. (XLNX)…

XLNX

Xilinx

$90.26

0.095 (0.11%)

ADI

Analog Devices

$113.87

-0.03 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

  • 28

    Jan

PYPL

PayPal

$104.52

-0.46 (-0.44%)

14:07
12/05/19
12/05
14:07
12/05/19
14:07
Periodicals
Breaking Periodicals news story on PayPal »

Hedgeye names PayPal a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

ALXN

Alexion

$107.06

-8.43 (-7.30%)

, REGN

Regeneron

$369.33

-0.67 (-0.18%)

14:03
12/05/19
12/05
14:03
12/05/19
14:03
Recommendations
Alexion, Regeneron analyst commentary  »

Piper Jaffray a buyer of…

ALXN

Alexion

$107.06

-8.43 (-7.30%)

REGN

Regeneron

$369.33

-0.67 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

CCEP

Coca-Cola European Partners

$50.07

-0.75 (-1.48%)

13:57
12/05/19
12/05
13:57
12/05/19
13:57
Periodicals
Einride to launch electric pod pilot with Coca-Cola European Partners, TC says »

Darrell Etherington of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,320.51

-0.95 (-0.07%)

13:37
12/05/19
12/05
13:37
12/05/19
13:37
Periodicals
Spain moving forward with 'Google tax' despite U.S. disappointment, El Pais says »

Spain is moving forward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WEC

WEC Energy

$89.00

-0.07 (-0.08%)

13:32
12/05/19
12/05
13:32
12/05/19
13:32
Earnings
Breaking Earnings news story on WEC Energy »

WEC Energy sees FY20 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEC

WEC Energy

$88.97

-0.1 (-0.11%)

13:31
12/05/19
12/05
13:31
12/05/19
13:31
Hot Stocks
WEC Energy plans to raise quarterly dividend to 63.25c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$15.77

-0.05 (-0.32%)

13:31
12/05/19
12/05
13:31
12/05/19
13:31
Hot Stocks
Teck announces new collective agreement at Carmen de Andacollo operations »

Teck Resourcesannounced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BIIB

Biogen

$298.44

9.09 (3.14%)

13:28
12/05/19
12/05
13:28
12/05/19
13:28
Recommendations
Biogen analyst commentary  »

Biogen doctor panel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

AAPL

Apple

$264.33

2.55 (0.97%)

13:28
12/05/19
12/05
13:28
12/05/19
13:28
Periodicals
Noted Apple analyst Kuo sees 2021 iPhone without lightning port, 9To5 Mac says »

Apple analyst Ming-Chi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
12/05/19
12/05
13:25
12/05/19
13:25
General news
Treasury Action: the markets have gone into a holding pattern »

Treasury Action: the…

13:25
12/05/19
12/05
13:25
12/05/19
13:25
Conference/Events
BTIG healthcare/biotech analysts to hold an analyst/industry conference call »

Analysts discuss the…

13:25
12/05/19
12/05
13:25
12/05/19
13:25
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

13:25
12/05/19
12/05
13:25
12/05/19
13:25
Conference/Events
House Financial Services Committee to hold a hearing »

The Subcommittee on…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/05/19
12/05
13:17
12/05/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.